Key facts
- Hong Kong is initiating clinical trials for breast cancer and eye treatments.
- The trials will span across the Greater Bay Area.
- This initiative seeks to speed up the availability of new medical therapies.
Hong Kong is taking the lead in launching clinical trials for breast cancer and eye treatments throughout the Greater Bay Area. This initiative is designed to accelerate the development and accessibility of innovative medical therapies for patients across the region. By leveraging the collaborative potential of the Greater Bay Area, Hong Kong aims to streamline the trial process and bring new treatments to market more efficiently.